Phathom Pharmaceuticals, Inc. (PHAT) Interest Expense USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Phathom Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2018 to 2024.
  • Phathom Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $17.2 M, a 86.3% increase year-over-year.
  • Phathom Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $49.9 M, a 47.9% increase year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Interest Expense for 2023 was $42 M, a 53.7% increase from 2022.
  • Phathom Pharmaceuticals, Inc. annual Interest Expense for 2022 was $27.3 M, a 302% increase from 2021.
  • Phathom Pharmaceuticals, Inc. annual Interest Expense for 2021 was $6.79 M, a 48.2% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $49.9 M $17.2 M +$7.95 M +86.3% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-06-14
Q4 2023 $42 M $13 M +$3.43 M +35.7% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-06-14
Q3 2023 $38.5 M $10.1 M +$830 K +8.95% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $37.7 M $9.62 M +$3.95 M +69.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $33.8 M $9.22 M +$6.46 M +234% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-06-14
Q4 2022 $27.3 M $9.6 M +$6.83 M +246% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-06-14
Q3 2022 $20.5 M $9.28 M +$7.79 M +525% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $12.7 M $5.67 M +$4.41 M +351% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $8.28 M $2.76 M +$1.49 M +117% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $6.79 M $2.78 M +$1.48 M +114% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $5.31 M $1.49 M +$199 K +15.5% Jul 1, 2021 Sep 30, 2021 10-Q/A 2022-11-09
Q2 2021 $5.11 M $1.26 M -$6 K -0.48% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $5.12 M $1.27 M +$534 K +72.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $4.58 M $1.3 M +$256 K +24.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $4.33 M $1.29 M -$704 K -35.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $5.03 M $1.26 M +$125 K +11% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $4.9 M $738 K +$727 K +6609% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $4.18 M $1.04 M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 $1.99 M +$1.99 M +49650% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $1.14 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $11 K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q3 2018 $4 K* Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.